PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironmentNatalie B. Collins(Boston Children's Hospital), W. Nicholas Haining(Broad Institute)Journal for ImmunoTherapy of CancerMarch 1, 202210.1136/jitc-2021-003402Cited by 118SaveCiteExport RISWatch citationsRelated PapersCD39 Expression Identifies Terminally Exhausted CD8+ T Cells|PLoS Pathogens|2015|390The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival|Nature|2017|354ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function|Blood|2008|88